Most statistical design and analysis methods for clinical trials have been developed and evaluated where at least several hundreds of patients could be recruited. These methods may not be suitable to evaluate therapies if the sample size is unavoidably small, which is usually termed by small populations. The specific sample size cut off, where the standard methods fail, needs to be investigated. In this paper, the authors present their view on new developments for design and analysis of clinical trials in small population groups, where conventional statistical methods may be inappropriate, e.g., because of lack of power or poor adherence to asymptotic approximations due to sample size restrictions
Since clinical trials for rare disease subjects have a small number of patients, it is difficult to ...
International audienceWhere there are a limited number of patients, such as in a rare disease, clini...
How should we approach trial design when we can get some, but not all, of the way to the numbers req...
Background: Most statistical design and analysis methods for clinical trials have been developed and...
Where there are a limited number of patients, such as in a rare disease, clinical trials in these sm...
Background: Small clinical trials are necessary when there are difficulties in recruiting enough pat...
Background Orphan drug development faces numerous challenges, including low disease prevalence, p...
Abstract Background IDeAl (Integrated designs and analysis of small population clinical trials) is a...
OBJECTIVE: Frequentist trials in Rare disease/small population trials often require unfeasibly large...
BACKGROUND: IDeAl (Integrated designs and analysis of small population clinical trials) is an EU fun...
Where there are a limited number of patients, such as in a rare disease, clinical trials in these sm...
Since clinical trials for rare disease subjects have a small number of patients, it is difficult to ...
International audienceWhere there are a limited number of patients, such as in a rare disease, clini...
How should we approach trial design when we can get some, but not all, of the way to the numbers req...
Background: Most statistical design and analysis methods for clinical trials have been developed and...
Where there are a limited number of patients, such as in a rare disease, clinical trials in these sm...
Background: Small clinical trials are necessary when there are difficulties in recruiting enough pat...
Background Orphan drug development faces numerous challenges, including low disease prevalence, p...
Abstract Background IDeAl (Integrated designs and analysis of small population clinical trials) is a...
OBJECTIVE: Frequentist trials in Rare disease/small population trials often require unfeasibly large...
BACKGROUND: IDeAl (Integrated designs and analysis of small population clinical trials) is an EU fun...
Where there are a limited number of patients, such as in a rare disease, clinical trials in these sm...
Since clinical trials for rare disease subjects have a small number of patients, it is difficult to ...
International audienceWhere there are a limited number of patients, such as in a rare disease, clini...
How should we approach trial design when we can get some, but not all, of the way to the numbers req...